Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

Natural Beauty Bio-Technology

OTCPK:NBBT.F
Snowflake Description

Excellent balance sheet with poor track record.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
NBBT.F
OTCPK
HK$1B
Market Cap
  1. Home
  2. US
  3. Household
Company description

Natural Beauty Bio-Technology Limited, an investment holding company, manufactures and sells skin care, beauty, aroma-therapeutic, and health supplements and make-up products under the Natural Beauty brand. The last earnings update was 6 days ago. More info.


Add to Portfolio Compare Print
NBBT.F Share Price and Events
7 Day Returns
0%
OTCPK:NBBT.F
12.3%
US Personal Products
12.5%
US Market
1 Year Returns
0%
OTCPK:NBBT.F
-14.7%
US Personal Products
-12.7%
US Market
NBBT.F Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Natural Beauty Bio-Technology (NBBT.F) 0% 22% 11.1% 0% -9.1% 33.3%
US Personal Products 12.3% -14.4% -25.5% -14.7% 19.9% 5.7%
US Market 12.5% -14.7% -21.5% -12.7% 5.4% 17.5%
1 Year Return vs Industry and Market
  • NBBT.F outperformed the Personal Products industry which returned -14.7% over the past year.
  • NBBT.F outperformed the Market in United States of America which returned -12.7% over the past year.
Price Volatility
NBBT.F
Industry
5yr Volatility vs Market

NBBT.F Value

 Is Natural Beauty Bio-Technology undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Natural Beauty Bio-Technology. This is due to cash flow or dividend data being unavailable. The share price is $0.1.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Natural Beauty Bio-Technology's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Natural Beauty Bio-Technology's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
OTCPK:NBBT.F PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-12-31) in HKD HK$0.01
SEHK:157 Share Price ** SEHK (2020-03-02) in HKD HK$0.65
United States of America Personal Products Industry PE Ratio Median Figure of 18 Publicly-Listed Personal Products Companies 11.01x
United States of America Market PE Ratio Median Figure of 2,942 Publicly-Listed Companies 12.96x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Natural Beauty Bio-Technology.

OTCPK:NBBT.F PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= SEHK:157 Share Price ÷ EPS (both in HKD)

= 0.65 ÷ 0.01

43.65x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Natural Beauty Bio-Technology is overvalued based on earnings compared to the US Personal Products industry average.
  • Natural Beauty Bio-Technology is overvalued based on earnings compared to the United States of America market.
Price based on expected Growth
Does Natural Beauty Bio-Technology's expected growth come at a high price?
Raw Data
OTCPK:NBBT.F PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 43.65x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
United States of America Personal Products Industry PEG Ratio Median Figure of 6 Publicly-Listed Personal Products Companies 1.64x
United States of America Market PEG Ratio Median Figure of 2,006 Publicly-Listed Companies 0.99x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Natural Beauty Bio-Technology, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Natural Beauty Bio-Technology's assets?
Raw Data
OTCPK:NBBT.F PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-12-31) in HKD HK$0.30
SEHK:157 Share Price * SEHK (2020-03-02) in HKD HK$0.65
United States of America Personal Products Industry PB Ratio Median Figure of 43 Publicly-Listed Personal Products Companies 1.81x
United States of America Market PB Ratio Median Figure of 5,143 Publicly-Listed Companies 1.26x
OTCPK:NBBT.F PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= SEHK:157 Share Price ÷ Book Value per Share (both in HKD)

= 0.65 ÷ 0.30

2.17x

* Primary Listing of Natural Beauty Bio-Technology.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Natural Beauty Bio-Technology is overvalued based on assets compared to the US Personal Products industry average.
X
Value checks
We assess Natural Beauty Bio-Technology's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Personal Products industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Personal Products industry average (and greater than 0)? (1 check)
  5. Natural Beauty Bio-Technology has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

NBBT.F Future Performance

 How is Natural Beauty Bio-Technology expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Natural Beauty Bio-Technology has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
19.2%
Expected Personal Products industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Natural Beauty Bio-Technology expected to grow at an attractive rate?
  • Unable to compare Natural Beauty Bio-Technology's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare Natural Beauty Bio-Technology's earnings growth to the United States of America market average as no estimate data is available.
  • Unable to compare Natural Beauty Bio-Technology's revenue growth to the United States of America market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
OTCPK:NBBT.F Future Growth Rates Data Sources
Data Point Source Value (per year)
United States of America Personal Products Industry Earnings Growth Rate Market Cap Weighted Average 19.2%
United States of America Personal Products Industry Revenue Growth Rate Market Cap Weighted Average 6.3%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 12.3%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7.3%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
OTCPK:NBBT.F Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in HKD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
OTCPK:NBBT.F Future Estimates Data
Date (Data in HKD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2020-12-31
2020-03-30
OTCPK:NBBT.F Past Financials Data
Date (Data in HKD Millions) Revenue Cash Flow Net Income *
2019-12-31 464 30
2019-09-30 423 18
2019-06-30 381 16 7
2019-03-31 375 46 17
2018-12-31 370 77 26
2018-09-30 390 112 61
2018-06-30 410 147 96
2018-03-31 405 84 101
2017-12-31 400 21 105
2017-09-30 409 9 105
2017-06-30 419 -4 104
2017-03-31 447 62 126

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if Natural Beauty Bio-Technology is high growth as no earnings estimate data is available.
  • Unable to determine if Natural Beauty Bio-Technology is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
OTCPK:NBBT.F Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Natural Beauty Bio-Technology Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

OTCPK:NBBT.F Future Estimates Data
Date (Data in HKD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2020-12-31
2020-03-30
OTCPK:NBBT.F Past Financials Data
Date (Data in HKD Millions) EPS *
2019-12-31 0.01
2019-09-30 0.01
2019-06-30 0.00
2019-03-31 0.01
2018-12-31 0.01
2018-09-30 0.03
2018-06-30 0.05
2018-03-31 0.05
2017-12-31 0.05
2017-09-30 0.05
2017-06-30 0.05
2017-03-31 0.06

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Natural Beauty Bio-Technology will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Examine Natural Beauty Bio-Technology's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  2. Natural Beauty Bio-Technology's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Household companies here
  3. While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Natural Beauty Bio-Technology's filings and announcements here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess Natural Beauty Bio-Technology's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Natural Beauty Bio-Technology has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

NBBT.F Past Performance

  How has Natural Beauty Bio-Technology performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Natural Beauty Bio-Technology's growth in the last year to its industry (Personal Products).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Natural Beauty Bio-Technology's year on year earnings growth rate was negative over the past 5 years and the most recent earnings are below average.
  • Natural Beauty Bio-Technology's 1-year earnings growth exceeds its 5-year average (13.5% vs -24.3%)
  • Natural Beauty Bio-Technology's earnings growth has not exceeded the US Personal Products industry average in the past year (13.5% vs 21.4%).
Earnings and Revenue History
Natural Beauty Bio-Technology's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Natural Beauty Bio-Technology Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

OTCPK:NBBT.F Past Revenue, Cash Flow and Net Income Data
Date (Data in HKD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-12-31 464.43 29.81 234.65
2019-09-30 422.55 18.42 224.44
2019-06-30 380.68 7.02 210.32
2019-03-31 375.10 16.64 199.98
2018-12-31 369.53 26.26 189.63
2018-09-30 389.61 61.14 185.39
2018-06-30 409.70 96.02 185.07
2018-03-31 404.64 100.71 175.46
2017-12-31 399.58 105.39 165.86
2017-09-30 409.08 104.61 170.77
2017-06-30 418.58 103.82 175.68
2017-03-31 446.90 126.11 181.12
2016-12-31 475.23 148.40 186.56
2016-09-30 478.67 144.89 198.93
2016-06-30 482.11 141.37 211.30
2016-03-31 494.51 139.10 229.06
2015-12-31 506.91 136.83 246.82
2015-09-30 514.60 128.50 252.30
2015-06-30 522.29 120.17 257.79
2015-03-31 514.03 95.82 260.07
2014-12-31 505.76 71.48 262.35
2014-09-30 495.05 61.65 266.91
2014-06-30 484.35 51.82 271.47
2014-03-31 461.88 55.05 269.11
2013-12-31 439.42 58.27 266.75
2013-09-30 437.77 81.75 244.49
2013-06-30 436.11 105.24 222.23
2013-03-31 459.78 112.25 228.43

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Natural Beauty Bio-Technology has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Natural Beauty Bio-Technology used its assets less efficiently than the US Personal Products industry average last year based on Return on Assets.
  • Natural Beauty Bio-Technology's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Natural Beauty Bio-Technology's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Personal Products industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Natural Beauty Bio-Technology has a total score of 1/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

NBBT.F Health

 How is Natural Beauty Bio-Technology's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Natural Beauty Bio-Technology's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Natural Beauty Bio-Technology is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Natural Beauty Bio-Technology's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Natural Beauty Bio-Technology's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 14.7x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Natural Beauty Bio-Technology Company Filings, last reported 2 months ago.

OTCPK:NBBT.F Past Debt and Equity Data
Date (Data in HKD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-12-31 599.54 24.96 145.70
2019-09-30 599.54 24.96 145.70
2019-06-30 559.01 0.00 159.62
2019-03-31 559.01 0.00 159.62
2018-12-31 551.86 0.00 181.02
2018-09-30 551.86 0.00 181.02
2018-06-30 601.96 0.00 320.50
2018-03-31 601.96 0.00 320.50
2017-12-31 650.75 0.00 288.90
2017-09-30 650.75 0.00 288.90
2017-06-30 604.13 0.00 373.05
2017-03-31 604.13 0.00 373.05
2016-12-31 654.67 0.00 428.63
2016-09-30 654.67 0.00 428.63
2016-06-30 747.36 0.00 563.78
2016-03-31 747.36 0.00 563.78
2015-12-31 732.63 0.00 502.72
2015-09-30 732.63 0.00 502.72
2015-06-30 795.86 0.00 648.13
2015-03-31 795.86 0.00 648.13
2014-12-31 773.91 0.00 583.28
2014-09-30 773.91 0.00 583.28
2014-06-30 783.66 0.00 599.56
2014-03-31 783.66 0.00 599.56
2013-12-31 788.26 0.00 507.41
2013-09-30 788.26 0.00 507.41
2013-06-30 782.31 0.00 463.08
2013-03-31 782.31 0.00 463.08
  • Natural Beauty Bio-Technology's level of debt (4.2%) compared to net worth is satisfactory (less than 40%).
  • Unable to establish if Natural Beauty Bio-Technology's debt level has increased without past 5-year debt data.
  • Debt is well covered by operating cash flow (64.5%, greater than 20% of total debt).
  • Interest payments on debt are well covered by earnings (EBIT is 262.9x coverage).
X
Financial health checks
We assess Natural Beauty Bio-Technology's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Natural Beauty Bio-Technology has a total score of 5/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

NBBT.F Dividends

 What is Natural Beauty Bio-Technology's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Natural Beauty Bio-Technology dividends.
If you bought $2,000 of Natural Beauty Bio-Technology shares you are expected to receive $0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Natural Beauty Bio-Technology's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Natural Beauty Bio-Technology's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
OTCPK:NBBT.F Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
United States of America Personal Products Industry Average Dividend Yield Market Cap Weighted Average of 8 Stocks 1.9%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 1946 Stocks 3%
United States of America Minimum Threshold Dividend Yield 10th Percentile 1.1%
United States of America Bottom 25% Dividend Yield 25th Percentile 2%
United States of America Top 25% Dividend Yield 75th Percentile 5.5%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

OTCPK:NBBT.F Future Dividends Estimate Data
Date (Data in HK$) Dividend per Share (annual) Avg. No. Analysts
2020-12-31
2020-03-30
OTCPK:NBBT.F Past Annualized Dividends Data
Date (Data in HK$) Dividend per share (annual) Avg. Yield (%)
2020-03-24 0.000 0.000
2019-08-29 0.000 0.000
2019-08-12 0.000 0.000
2019-04-02 0.000 0.000
2019-03-20 0.000 0.000
2018-09-17 0.053 6.631
2018-08-30 0.053 6.346
2018-04-19 0.056 8.667
2018-03-27 0.056 9.226
2017-09-11 0.080 13.228
2017-08-24 0.080 11.669
2017-05-25 0.074 9.445
2016-06-16 0.068 8.282
2015-08-27 0.078 9.309
2015-05-22 0.064 9.936
2014-09-11 0.042 6.443
2014-08-25 0.042 7.866
2014-05-16 0.026 6.729
2013-08-16 0.013 2.781
2013-04-09 0.023 3.866
2013-03-19 0.023 3.324
2012-04-10 0.085 9.018
2011-08-23 0.080 6.512
2011-03-24 0.080 4.649
2010-08-17 0.075 4.041
2010-03-25 0.075 5.354
2009-08-12 0.069 5.038
2009-04-15 0.084 6.910

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Natural Beauty Bio-Technology has not reported any payouts.
  • Unable to verify if Natural Beauty Bio-Technology's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Natural Beauty Bio-Technology's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Natural Beauty Bio-Technology has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Natural Beauty Bio-Technology's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.1%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Natural Beauty Bio-Technology afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Natural Beauty Bio-Technology has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

NBBT.F Management

 What is the CEO of Natural Beauty Bio-Technology's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Yen-Ling Lin
COMPENSATION HK$1,382,195
AGE 56
TENURE AS CEO 1.4 years
CEO Bio

Ms. Lin Yen-Ling has been Chief Executive Officer of Natural Beauty Bio-Technology Limited since October 26, 2018. She has been working in Eastern Group since May 2018 as Chief Marketing & Sales Officer of Eastern Media International Corp., Chief Marketing Officer of Eastern Home Shopping & Leisure Co., Ltd., and Chief Sales Officer of ETtoday Co., Ltd. Prior to this appointment, Ms. LIN was the general manager of Lintas China Group from 2016 to 2017. From 1997 to 2016, Ms. LIN had worked at Eastern Broadcasting Co., Ltd. as Chief Operation and Sales Officer and Havas Worldwide as Executive Vice President of Greater China and Chief Executive Officer of Taiwan. She graduated with a Bachelor of Arts degree from National Chengchi University in Taiwan.

CEO Compensation
  • Insufficient data for Yen-Ling to compare compensation growth.
  • Yen-Ling's remuneration is lower than average for companies of similar size in United States of America.
Management Team Tenure

Average tenure and age of the Natural Beauty Bio-Technology management team in years:

1.4
Average Tenure
60
Average Age
  • The average tenure for the Natural Beauty Bio-Technology management team is less than 2 years, this suggests a new team.
Management Team

Joanna Lei

TITLE
Executive Chairperson
COMPENSATION
HK$167K
AGE
60

Yen-Ling Lin

TITLE
Chief Executive Officer
COMPENSATION
HK$1M
AGE
56
TENURE
1.4 yrs

Yen-Yu Tsai

TITLE
Founder & Honorary Chairman
COMPENSATION
HK$1M
AGE
71
TENURE
48.2 yrs

Shu-Hwa Yang

TITLE
Chief Operating Officer
COMPENSATION
HK$2M
AGE
62

Ivan Pan

TITLE
Executive Director
COMPENSATION
HK$167K
AGE
47

Jenny Zhu

TITLE
Chief Legal Counsel

Ah Tsang Sun

TITLE
Company Secretary
TENURE
1 yrs
Board of Directors Tenure

Average tenure and age of the Natural Beauty Bio-Technology board of directors in years:

1.4
Average Tenure
67
Average Age
  • The average tenure for the Natural Beauty Bio-Technology board of directors is less than 3 years, this suggests a new board.
Board of Directors

Yen-Yu Tsai

TITLE
Founder & Honorary Chairman
COMPENSATION
HK$1M
AGE
71
TENURE
1.4 yrs

Ivan Pan

TITLE
Executive Director
COMPENSATION
HK$167K
AGE
47
TENURE
1.4 yrs

Steve Chen

TITLE
Independent Non-Executive Director
COMPENSATION
HK$240K
AGE
71
TENURE
10 yrs

Joanna Lei

TITLE
Executive Chairperson
COMPENSATION
HK$167K
AGE
60
TENURE
1.4 yrs

Chi-Chant Lu

TITLE
Independent Non-Executive Director
COMPENSATION
HK$240K
AGE
68
TENURE
4.3 yrs

George Yang

TITLE
Independent Non-Executive Director
COMPENSATION
HK$30K
AGE
73
TENURE
1.3 yrs

Vicky Lu

TITLE
Non-Executive Drector
COMPENSATION
HK$196K
AGE
54
TENURE
1.3 yrs

Shu-Hua Lin

TITLE
Non-Executive Director
AGE
56
TENURE
1.3 yrs

Shou-Huang Chen

TITLE
Non-Executive Director
AGE
67
TENURE
1.2 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
X
Management checks
We assess Natural Beauty Bio-Technology's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Natural Beauty Bio-Technology has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

NBBT.F News

Simply Wall St News

NBBT.F Company Info

Description

Natural Beauty Bio-Technology Limited, an investment holding company, manufactures and sells skin care, beauty, aroma-therapeutic, and health supplements and make-up products under the Natural Beauty brand. It also offers skin treatment, beauty and spa, and skin care consulting and beauty training services. Its spas provide various services, including hydrotherapy, facial treatment, body care, and skin care analysis. In addition, the company engages in the wholesale and retail of skin care and beauty products. It operates in the People’s Republic of China, Hong Kong, Taiwan, and Malaysia. The company was founded in 1976 and is based in Wan Chai, Hong Kong.

Details
Name: Natural Beauty Bio-Technology Limited
NBBT.F
Exchange: OTCPK
Founded: 1976
HK$167,885,649
2,002,100,932
Website: http://www.nblife.com
Address: Natural Beauty Bio-Technology Limited
Hopewell Centre,
Level 54,
Wan Chai,
Hong Kong
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
SEHK 157 Ordinary Shares The Stock Exchange of Hong Kong Ltd. HK HKD 28. Mar 2002
OTCPK NBBT.F Ordinary Shares Pink Sheets LLC US USD 28. Mar 2002
Number of employees
Current staff
Staff numbers
606
Natural Beauty Bio-Technology employees.
Industry
Personal Products
Household
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/03/30 03:49
End of day share price update: 2020/03/02 00:00
Last estimates confirmation: 2019/12/18
Last earnings filing: 2020/03/24
Last earnings reported: 2019/12/31
Last annual earnings reported: 2019/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.